 |
The IMPAHCT (International Meeting on Pulmonary Hypertension Clinical Treatment) event, organized by the pharmaceutical company Ferrer, has brought together more than 150 pulmonologists and cardiologists from over 30 countries, consolidating the company’s commitment to the advancement of the research and treatment of pulmonary hypertension.
One of the main topics discussed during the event was the importance of referring patients to specialized centers as early as possible. Recent data show…
– 출처 : https://www.newswire.co.kr/newsRead.php?no=969948&sourceType=rss